Browse > Article
http://dx.doi.org/10.4069/kjwhn.2013.19.4.201

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy  

Jeong, Ju-Hyeon (Asan Medical Center)
Nho, Ju-Hee (Department of Nursing, University of Ulsan)
Kim, Gi-Suk (Asan Medical Center)
Lee, Young-Eun (Asan Medical Center)
Yu, Sun-Young (Asan Medical Center)
Lee, Hyun-Ju (Asan Medical Center)
Sim, Yu-Mi (Asan Medical Center)
Lee, Young-Sun (Asan Medical Center)
Publication Information
Women's Health Nursing / v.19, no.4, 2013 , pp. 201-210 More about this Journal
Abstract
Purpose: The purpose of this study was to identify chemotherapy induced peripheral neuropathy, quality of life of patients with gynecologic cancer. Methods: This was a cross-sectional survey design. We collected 130 patients with gynecologic cancer. They complete a self reported questionnaire including items related neuropathy and quality of life (FACT-GOG/Ntx subscale, FACT-G scale). Results: The neuropathy score was $14.3{\pm}7.9$. The quality of life score was $64.8{\pm}16.4$. The neuropathy induced significant difference according to diabetic status, difficulties in performing household chores and willing to discontinuity of chemotherapy. And duration of cancer diagnosis, neuropathy, number of total chemo agent associated with quality of life. There was a negative correlation between number of total chemo agent and quality of life. Neuropathy independently affected quality of life. Conclusion: Chemotherapy induced peripheral neuropathy of patients with gynecologic cancer adversely affected women's quality of life and activities of daily living. To improve patient's quality of life, it is important that accurate assess and appropriately manage neuropathy in patients with gynecologic cancer.
Keywords
Gynecologic neoplasm; Chemotherapy induced peripheral neuropathy; Quality of life;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bakitas, M. A. (2007). Background noise: The experience of chemotherapy- induced peripheral neuropathy. Nursing Research, 56, 323-331. http://dx.doi.org/10.1097/01.nnr.0000 289503.22414.79   DOI
2 Bartlett, J. E., Kotrlik, J. W., & Higgins, C. C. (2001). Organizational research: Determining appropriate sample size in survey research. Information Technology, Learning, and Performance Journal, 19, 43-50.
3 Berek, J. S. (2007). Berek & Novak's Gynecology (14ed.). Philadelphia: Lippincott.
4 Calhoun, E. A., Welshman, E. E., Chang, C. H., Lurain, J. R., Fishman, D. A., Hunt, T. L., et al. (2003). Psychometric evaluation of functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity(FACT/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecologic Oncology, 13, 741-748.   DOI   ScienceOn
5 Cella, D. (1997). Manual of the functional assessment of chronic illness therapy (FACIT) measurement system. Evanston, IL: Center on outcomes, research and education (CORE), Evanston Northwestern Healthcare and Northwestern University.
6 Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006). Diagnosis, management, and evaluation of chemotherapy induced peripheral neuropathy. Seminars in Oncology, 33, 15-49.
7 Kaley, T. J., & Deangelis, L. M. (2009). Therapy of chemotherapyinduced peripheral neuropathy. British Journal of Haematology, 145, 3-14. http://dx.doi.org/10.1111/j.1365-2141.2008. 07558.x   DOI   ScienceOn
8 Kim, H. M. (2012). Symptoms and relief therapy related to chemotherapy induced peripheral neuropathy in patients with cancer. Unpublished master's thesis, Keimyoung University, Daegu.
9 Kim, J. H., Choi, K. S., Kim, T. W., & Hong, Y. S. (2011). Quality of life in colorectal cancer patients with chemotherapy induced peripheral neuropathy. Journal of Korean Oncology Nursing, 11, 254-262. http://dx.doi.org/10.5388/jkon.2011. 11.3.254   DOI
10 Kiser, D. W., Greer, T. B., Wilmoth, M. C., Dmochowski, J., & Naumann, R. W. (2010). Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: Patient reports and provider assessments. Oncology Nursing Forum, 37, 758-764. http://dx.doi.org/10.1188/10.ONF.758-764   DOI   ScienceOn
11 Kwak, M. K., Kim, E. J., Lee, E. R., Kwon, I. G., & Hwang, M. S. (2010). Characteristics and quality of life in patients with chemotherapy induced peripheral neuropathy. Journal of Korean Oncology Nursing, 10, 231-239.   DOI
12 Long, H. J., Monk, B. J., Huang, H. Q., Grendys, E. C., Mc- Meekin, D. S., Sorosky, J., et al. (2006). Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A gynecologic oncology group study. Gynecologic Oncology, 100, 537-543.   DOI   ScienceOn
13 Mantyh, P. W. (2006). Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience, 7, 797-809.   DOI   ScienceOn
14 Smith, E. L., Whedon, M. B., & Bookbinder, M. (2002). Quality improvement of painful peripheral neuropathy. Seminars in Oncology Nursing, 18, 36-43.   DOI   ScienceOn
15 Pan, Y., & Kao, M. S. (2007). Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy. International Journal of Gynecological Cancer, 17, 394-397. http://dx.doi.org/10.1111/j.1525-1438. 2006.00766.x   DOI   ScienceOn
16 Park, A. R., Kim, S. J., Bang, J. S., & La, H. O. (2009). Oxaliplatininduced peripheral neuropathy in patients with advanced or metastatic gastric cancer. The Korean Journal of Clinical Pharmacy, 19, 18-22.
17 Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., et al. (2007). Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, cross-over trial. Cancer, 110, 2110-2118. http://dx. doi.org/10.1002/cncr.23008   DOI   ScienceOn
18 Smith, E. M., Beck, S. L., & Cohen, J. (2008). The total neuropathy score: A tool for measuring chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 35, 96-102. http://dx.doi.org/10.1188/08.ONF.96-102   DOI   ScienceOn
19 Statistics Korea. (2010). Cancer occurrence ratio in Korea women. Retrieved July, 15, 2013, from http://kosis.kr/wnsearch/ totalSearch.jsp
20 Sweeney, C. W. (2002). Understanding peripheral neuropathy in patients with cancer: Background and patients assessment. Clinical Journal of Oncology Nursing, 6, 163-166.   DOI   ScienceOn
21 Tofthagen, C. (2010). Patient perceptions associated with chemotherapy- induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 14, E22-E28. http://dx.doi.org/10.1188/ 10.CJON.E22-E28   DOI   ScienceOn
22 Tofthagen, C., McAllister, R. D., & McMillan, S. C. (2011). Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clinical Journal of Oncology Nursing, 15 , 182-188. http://dx.doi.org/10.1188/11.CJON.182-188   DOI   ScienceOn
23 Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008). Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. European Journal of Cancer, 44, 1507-1515. http://dx.doi.org/10.1016/j.ejca.2008. 04.018   DOI   ScienceOn
24 Verstappen, C. C., Heimans, J. J., Hoekman, K., & Postma, T. J. (2003). Neurotoxic complication of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs, 63, 1549-1563.   DOI   ScienceOn
25 Viens, P., Petit, T., Yovine, A., Bougnoux, P., Deplanque, G., Cottu, P. H., et al. (2006). A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients. Annuals of Oncology, 17, 429- 436. http://dx.doi.org/10.1093/annonc/mdj097   DOI   ScienceOn
26 Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11 , 361-376.   DOI   ScienceOn
27 Yarbro, C. H., Frogge, M. H., & Goodman, M. (2004). Cancer symptom management (3rd ed.). Boston: Jones and Bartlett.